Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Morizane

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Gastroenterology|July 16, 2003
A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapyMinoru Shibata, Katsuhiko Yanaga, Toshio Morizane, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 31, 2002
Inhibition of growth of human hepatoma cells by dual-function antisense IL-6 oligonucleotidesNaoki Kumagai, Kanji Tsuchimoto, Satoshi Tsunematsu, et al.
Hepato-Gastroenterology|April 11, 2007
Values of Doppler sonography predicts high risk variceal bleeding in patients with viral cirrhosisTetsuya Tsubaki, Shinpei Sato, Hirotoshi Fujikawa, et al.
The American Journal of Emergency Medicine|June 12, 2018
Interleukin-6 as a diagnostic marker for infection in critically ill patients: A systematic review and meta-analysisShinya Iwase, Taka-Aki Nakada, Noriyuki Hattori, et al.
BMC Cancer|May 23, 2012
Customized chemotherapy based on epidermal growth factor receptor mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trialShiro Fujita, Nobuyuki Katakami, Katsuhiro Masago, et al.
Hepatology (Baltimore, Md.)|May 1, 2002
Hepatocellular carcinoma and survival in patients with primary biliary cirrhosisAkitaka Shibuya, Katsuaki Tanaka, Hiroshi Miyakawa, et al.
Inflammatory Intestinal Diseases|June 8, 2019
A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFαTakuya Masuda, Atsushi Yoshida, Fumiaki Ueno, et al.
Radiology|October 18, 2003
Differential diagnosis of hepatic tumors by using contrast enhancement patterns at USTetsuo Isozaki, Kazushi Numata, Takayoshi Kiba, et al.
Liver|March 22, 2002
Mannose-binding lectin and the prognosis of fulminant hepatic failure caused by HBV infectionYukiya Hakozaki, Makoto Yoshiba, Kazuhiko Sekiyama, et al.
The Tokai Journal of Experimental and Clinical Medicine|February 9, 2011
Predictive factors for the response to lamivudine in HBV-infected patients with chronic hepatitis and cirrhosisYasuhiro Nishizaki, Toshio Morizane, Seiichiro Kojima, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Gastroenterology|July 16, 2003
A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapyMinoru Shibata, Katsuhiko Yanaga, Toshio Morizane, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 31, 2002
Inhibition of growth of human hepatoma cells by dual-function antisense IL-6 oligonucleotidesNaoki Kumagai, Kanji Tsuchimoto, Satoshi Tsunematsu, et al.
Hepato-Gastroenterology|April 11, 2007
Values of Doppler sonography predicts high risk variceal bleeding in patients with viral cirrhosisTetsuya Tsubaki, Shinpei Sato, Hirotoshi Fujikawa, et al.
The American Journal of Emergency Medicine|June 12, 2018
Interleukin-6 as a diagnostic marker for infection in critically ill patients: A systematic review and meta-analysisShinya Iwase, Taka-Aki Nakada, Noriyuki Hattori, et al.
BMC Cancer|May 23, 2012
Customized chemotherapy based on epidermal growth factor receptor mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trialShiro Fujita, Nobuyuki Katakami, Katsuhiro Masago, et al.
Hepatology (Baltimore, Md.)|May 1, 2002
Hepatocellular carcinoma and survival in patients with primary biliary cirrhosisAkitaka Shibuya, Katsuaki Tanaka, Hiroshi Miyakawa, et al.
Inflammatory Intestinal Diseases|June 8, 2019
A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFαTakuya Masuda, Atsushi Yoshida, Fumiaki Ueno, et al.
Radiology|October 18, 2003
Differential diagnosis of hepatic tumors by using contrast enhancement patterns at USTetsuo Isozaki, Kazushi Numata, Takayoshi Kiba, et al.
Liver|March 22, 2002
Mannose-binding lectin and the prognosis of fulminant hepatic failure caused by HBV infectionYukiya Hakozaki, Makoto Yoshiba, Kazuhiko Sekiyama, et al.
The Tokai Journal of Experimental and Clinical Medicine|February 9, 2011
Predictive factors for the response to lamivudine in HBV-infected patients with chronic hepatitis and cirrhosisYasuhiro Nishizaki, Toshio Morizane, Seiichiro Kojima, et al.
Pageof 4